Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Pj Ho"'
Autor:
DR Zain, SP Iyer, RA Sica, PJ Ho, B Hu, A Prica, W-K Weng, YH Kim, MS Khodadoust, ML Palomba, FM Foss, K Tipton, EL Cullingford, SM Horwitz, A Sharma
Publikováno v:
European Journal of Cancer. 173:S21
Publikováno v:
Cancer Research. 78:P6-08
This abstract was not presented at the symposium.
Autor:
Karieshma Kabani, Narelle Woodland, Esther Aklilu, Pj Ho, Regan Brown, Douglas E. Joshua, S Yang, Suzanne Reid
Publikováno v:
International Journal of Laboratory Hematology. 32:e190-e196
Summary Introduction: The use of CD138 to isolate CD138 + plasma cells (PCs) from plasma cell myeloma (PCM) patients’ bone marrow samples has been used extensively in myeloma research. We sought to highlight the problem with this selection process,
Autor:
Catherine E Oldenburg, Thomas M Lietman, Ali Sie, Kieran S O'Brien, Elodie Lebas, Mamadou Bountogo, Jessica Brogdon, Valentin Boudo, Amza Abdou, Paul Emerson, Huiyu Hu, Ahmed Mamane Arzika, Ramatou Maliki, Alio Karamba Mankara, Mamadou Outtara, Fanny Yago-Wienne, Issouf Bamba, Charles Knirsch, PJ Hooper, Fanice Nyatigo
Publikováno v:
BMJ Global Health, Vol 7, Iss 10 (2022)
Background To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old
Externí odkaz:
https://doaj.org/article/1853ddf9df714d92b5af462afeb054fc
Autor:
PJ Hore
Publikováno v:
eLife, Vol 8 (2019)
Prolonged exposure to weak (~1 μT) extremely-low-frequency (ELF, 50/60 Hz) magnetic fields has been associated with an increased risk of childhood leukaemia. One of the few biophysical mechanisms that might account for this link involves short-lived
Externí odkaz:
https://doaj.org/article/924e8b4b466e465c9998cc471660229b
Publikováno v:
Biology of Sport, Vol 32, Iss 4, Pp 275-280 (2015)
The objective of the study was to examine salivary biomarker response to fluid consumption in exercising athletes. Exercise induces stress on the body and salivary alpha amylase (sAA) and salivary cortisol are useful biomarkers for activity in the sy
Externí odkaz:
https://doaj.org/article/f1c25dc0faac42a7be96370742db6786
Autor:
Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: spiyer@mdanderson.org., Sica RA; Department of Oncology, Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY, USA., Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW, Australia., Prica A; Princess Margaret Cancer Centre, Toronto, Canada., Zain J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Foss FM; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Hu B; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL, USA., Weng WK; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Kim YH; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Huen AO; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams LM; CRISPR Therapeutics, Boston, MA, USA., Ma A; CRISPR Therapeutics, Boston, MA, USA., Huang E; CRISPR Therapeutics, Boston, MA, USA., Ganpule A; CRISPR Therapeutics, Boston, MA, USA., Nagar SD; CRISPR Therapeutics, Boston, MA, USA., Sripakdeevong P; CRISPR Therapeutics, Boston, MA, USA., Cullingford EL; CRISPR Therapeutics, Boston, MA, USA., Karnik S; CRISPR Therapeutics, Boston, MA, USA., Dequeant ML; CRISPR Therapeutics, Boston, MA, USA., Patel JN; CRISPR Therapeutics, Boston, MA, USA., He XS; CRISPR Therapeutics, Boston, MA, USA., Li Z; CRISPR Therapeutics, Boston, MA, USA., He QA; CRISPR Therapeutics, Boston, MA, USA., Mendonez JH; CRISPR Therapeutics, Boston, MA, USA., Keegan A; CRISPR Therapeutics, Boston, MA, USA., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Nov 28. Date of Electronic Publication: 2024 Nov 28.
Autor:
Lim KJC; Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia; Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Melbourne Australia. Electronic address: Kenneth.lim@svha.org.au., Wellard C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Moore E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Ninkovic S; Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia; Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Melbourne Australia; Department of Medicine, University of Melbourne, Melbourne, Australia., Chng WJ; National University Cancer Institute, National University Health System, Singapore; Cancer Science Institute of Singapore, and Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Spencer A; Department of Haematology, The Alfred Hospital, Melbourne Australia; Department of Haematology, Monash Health, Melbourne Australia., Mollee P; Department of Haematology, Princess Alexandra Hospital, Brisbane Australia., Hocking J; Department of Haematology, Austin Health, Melbourne Australia., Ho PJ; Department of Haematology, Royal Prince Alfred Hospital, Sydney, Australia; University of Sydney, Sydney, Australia., Janowski W; Calvary Mater Newcastle Hospital, Newcastle, Australia., Kim K; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., McCaughan G; Department of Haematology, St Vincent's Hospital Sydney, Sydney, Australia; Garvan Institute of Medical Research, Sydney, Australia; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Dun K; Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Melbourne Australia., McQuilten ZK; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Haematology, Monash Health, Melbourne Australia., Chen F; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Quach H; Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Nov 09. Date of Electronic Publication: 2024 Nov 09.
Autor:
Fouda AEA; Department of Physics, The University of Chicago, Chicago, Illinois 60637, United States.; Chemical Sciences and Engineering Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, Illinois 60439, United States., Southworth SH; Chemical Sciences and Engineering Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, Illinois 60439, United States., Ho PJ; Chemical Sciences and Engineering Division, Argonne National Laboratory, 9700 S. Cass Avenue, Lemont, Illinois 60439, United States.
Publikováno v:
Journal of chemical theory and computation [J Chem Theory Comput] 2024 Oct 22; Vol. 20 (20), pp. 8782-8794. Date of Electronic Publication: 2024 Oct 11.
Autor:
Favaloro J; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales. james.favaloro@health.nsw.gov.au., Bryant CE; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales., Abadir E; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales., Gardiner S; Sydney Local Health District Clinical Research Institute, Royal Prince Alfred Hospital, Camperdown, New South Wales., Yang S; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales., King T; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales., Nassif N; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales., O'Brien BA; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales., Sedger LM; Institute for Clinical Pathology and Medical Research (ICPMR), New South Wales Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Center for Virus Research, Westmead Institute for Medical Research, Westmead, New South Wales., Boyle R; Orthopedics Department, Sydney Local Health District, Royal Prince Alfred Hospital, Camperdown, New South Wales., Joshua DE; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales., Ho PJ; Institute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, NSW.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.